- Associated Press•14 days ago
The Beverly Hills, California-based company said it had a loss of 26 cents per share. The biotechnology company posted revenue of $1.1 million in the period. In the final minutes of trading on Monday, ...
- PR Newswire•14 days ago
LOS ANGELES, Aug. 15, 2016 /PRNewswire/ -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, ...
- Accesswire•14 days agoInvestor Calendar Invites You to the Capricor Therapeutics Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 15, 2016
LOS ANGELES, CA / ACCESSWIRE / August 15, 2016 / Capricor Therapeutics, Inc. (NASDAQ: CAPR) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held August ...
Capricor Therapeutics, Inc. (CAPR)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||3.36 x 200|
|Ask||3.55 x 1000|
|Day's Range||3.37 - 3.50|
|52wk Range||1.88 - 5.40|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.71|
|Avg Vol (3m)||33,787|
|Dividend & Yield||N/A (N/A)|